-
Unchained Labs 0 Open PositionsHere’s the deal. We’re all about helping biologics and gene therapy researchers break free from tools that just don’t cut it. Unleashing problem-tackling products....
-
Ultragenyx 0 Open PositionsAt Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right....
-
Turn Biotechnologies 0 Open PositionsWe are a biotechnology company focused on restoring cells’ youthful vigor to repair damage caused by the aging process. Using a proprietary ERA™ Platform,....
-
TrueBinding 0 Open PositionsResearching and developing first-in-class monoclonal antibody drugs to treat tumor, fibrotic diseases, metabolic diseases, autoimmune diseases and neurologic diseases.
-
Tranquis Therapeutics 0 Open PositionsTranquis Therapeutics is a breakthrough biopharmaceutical company focused on developing a portfolio of promising small molecule drugs with a unique mechanism of action, capable....
-
Tizona Therapeutics 0 Open PositionsTizona Therapeutics, Inc., is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Founded by....
-
Tierra Biosciences 0 Open PositionsTierra Biosciences is a synthetic biology company that accelerates the pace of discovery and enables the next generation of bio-based materials. Tierra’s first product,....
-
Therini Bio 0 Open PositionsTherini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to....
-
Ten Sixteen Bio 0 Open PositionsTenSixteen Bio is the first company to leverage somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics to....
-
Tempest Therapeutics 0 Open PositionsTempest Therapeutics is a clinical-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways. Tempest has a balanced and deep pipeline consisting....